Bushra Ijaz

494 citations
27 papers · 383 indexed · h-index 13
Topics
Hepatitis C virus research (15 papers)Hepatitis B Virus Studies (11 papers)Liver Disease Diagnosis and Treatment (8 papers)

In The Last Decade

Bushra Ijaz

27 papers receiving 374 citations

Peers

Bushra Ijaz
Comparison fields: 5 of 69
  • Hepatology 179
  • Epidemiology 143
  • Molecular Biology 108
  • Pharmaceutical Science 34
  • Pharmacology 31
Replace Xue Zhou with:
Xue Zhou China
Satoshi Sobue Japan
Iara Fabrícia Kretzer Brazil
Mengyun Ke China
Honghui Shen China
Yoshitaka Shirasago Japan
Placido Franco Italy
Gaofeng Lu China
Yongqiang Shan China
Muhammad Ashfaq–Khan Germany
Bushra Ijaz relative to Xue Zhou China Xue Zhou's profile →
Citations per field
00.5×1.5×2.3×
Xue Zhou · 1×
Citations per year

Countries citing papers authored by Bushra Ijaz

Since Specialization
Citations

This map shows the geographic impact of Bushra Ijaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bushra Ijaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bushra Ijaz more than expected).

Fields of papers citing papers by Bushra Ijaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bushra Ijaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bushra Ijaz. The network helps show where Bushra Ijaz may publish in the future.

Co-authorship network of co-authors of Bushra Ijaz

This figure shows the co-authorship network connecting the top 25 collaborators of Bushra Ijaz. A scholar is included among the top collaborators of Bushra Ijaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bushra Ijaz. Bushra Ijaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4
In vitro phytochemical and anticancer activity of Misopates orontium L. and Dicliptera bupleuroides Nees.
1
5 18
6 9
7 39
8 20
9 46
10 5
11 16
12 14
13 5
14 12
15 12
16 28
17 24
18 18
19 19
20 29

About Bushra Ijaz

Bushra Ijaz is a scholar working on Hepatology, Pharmacology and Pharmaceutical Science, having authored 27 papers that have together received 383 indexed citations. Recurring topics across this work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (8 papers). The work is most often cited by research in Hepatology (179 citations), Pharmaceutical Science (34 citations) and Epidemiology (143 citations). Bushra Ijaz has collaborated with scholars based in Pakistan, United States and United Arab Emirates. Frequent co-authors include Sajida Hassan, Waqar Ahmad, Shah Jahan, Saba Khaliq, Sheikh Riazuddin, Sidra Rehman, Sultan Asad, Usman Ali Ashfaq, Syed Aun Muhammad and Nighat Fatima. Their work appears in journals such as Biotechnology Advances, International Journal of Biological Macromolecules and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026